Medical Care for Athletes with Hemophilia

Athletic Therapy Today

Volumn 9, Issue 2, 2004, Pages 16-19

  Fiala, Kelly A ^a   Ritenour, Donna M ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

DDAVP; Factor VIII; Medical clearance

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ABDOMINAL CRAMP; ATHLETE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD DONOR; CLINICAL FEATURE; CLINICAL TRIAL; COMMON COLD; DISEASE SEVERITY; DRUG COST; EMERGENCY TREATMENT; FITNESS; FLUSHING; HEALTH CARE PERSONNEL; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MEDICAL CARE; MEDICAL DECISION MAKING; MUSCLE STRENGTH; NAUSEA; NOSE CONGESTION; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; SPORT; SPORTS MEDICINE; TREATMENT OUTCOME; TREATMENT PLANNING; VOCATIONAL EDUCATION;

EID: 1542410187     PISSN: 10787895     EISSN: None     Source Type: Journal    
DOI: 10.1123/att.9.2.16     Document Type: Review

References (19)

1. Harmening D. Clinical Hematology and Fundamentals of Homeostasis. Philadelphia, Pa: FA Davis Co: 1997.
2. Rizza C. Oxford Textbook of Pathology 2b. Oxford: Oxford University Press; 1992.
3. Fiala K, Hoffmann S, Ritenour D. A survey of team physicians on participation status of hemophiliacs in NCAA Division I athletics. J Athletic Train. 2003;58(3):245-251.
4. Fiala K, Hoffmann S, Ritenour D. Traumatic hemarthrosis of the knee secondary to hemophilia A in a collegiate soccer player: a case report. J Athletic Train. 2002;37(3):315-319.
5. McLain L, Heldrich F. Hemophilia and sports: guidelines for participation. Physician Sportsmed. 1990;18(11):73-80.
6. Cohen A, Kessler C. Treatment of inherited coagulation disorders. Am J Med. 1995;99:675-682.
7. Hirsch S, Parvin S, Hirsch P. Musculoskeletal problems in hemophilia. Primary Care. 1980;7(2):311-316.
8. Ribbans W, Giangrande P, Beeton K. Conservative treatment of hemarthrosis for prevention of hemophilic synovitis. Clin Orthop Rel Res. 1997;343:12-18.
9. Arnheim D. Principles of Athletic Training. 9th ed. St Louis, Mo: Mosby Year Book; 1997.
10. Mannucci P, Tuddenham E. The hemophilias: progress and problems. Semin Hematol. 1999;36(4):104-117.
11. Giangrande P. DDAVP. Available at: http://www.medicine.ox.ac.uk/ohc/DDAVP. Accessed November 1997.
12. Rose EH, Aledort LM. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Intern Med. 1991;114:563-568.
13. Target Pharmacy. DDAVP nasal spray. Database Edition 00.1. First DataBank, Inc; 2000.
14. National Hemophilia Foundation, American Red Cross. Hemophilia, Sports, and Exercise. New York, NY: author; 1996.
15. Dunn AL, Powers JR, Ribeiro MJ, Rickles FR, Abshire TC. Adverse events during use of intranasal desmopressin acetate for hemophilia A and von Willebrand disease: a case report and review of 40 patients. Haemophilia. 2000;6:11-14.
16. McEvoy GK. American Hospital Formulary Service Drug Information. Bethesda, Md: American Society of Health-System Pharmacists, Inc; 2001.
17. Atkins R, Henderson N, Duthie R. Joint contractures in the hemophilias. Clin Orthop Rel Res. 1987;219:96-106.
18. Coelho J, Cameron K. Hemophilia and resistance training: implications for strength and conditioning professionals. Strength Cond J. 1999;21(5):30-33.
19. Houghton G, Duthie R. Orthopedic problems in hemophilia. Clin Orthop Rel Res. 1979;138:197-216.